Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Laydon

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Plos Pathogens|March 15, 2014
Clonality of HTLV-2 in natural infectionAnat Melamed, Aviva D Witkover, Daniel J Laydon, et al.
Plos Pathogens|April 18, 2013
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivoNicolas A Gillet, Lucy Cook, Daniel J Laydon, et al.
Retrovirology|January 10, 2016
Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipientsLucy B M Cook, Anat Melamed, Maria Antonietta Demontis, et al.
Scientific Reports|August 12, 2021
Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modellingSwapnil Mishra, James A Scott, Daniel J Laydon, et al.
Nature Communications|September 26, 2025
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemicCharles Whittaker, Gregory Barnsley, Daniela Olivera Mesa, et al.
Vaccine|May 2, 2021
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysisAlexandra B Hogan, Peter Winskill, Oliver J Watson, et al.
Plos Medicine|November 30, 2016
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison StudyStefan Flasche, Mark Jit, Isabel Rodríguez-Barraquer, et al.
Nature|March 26, 2021
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in EnglandErik Volz, Swapnil Mishra, Meera Chand, et al.
Science Translational Medicine|June 23, 2021
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in EnglandEdward S Knock, Lilith K Whittles, John A Lees, et al.
BMC Medicine|October 9, 2020
Response to COVID-19 in South Korea and implications for lifting stringent interventionsAmy Dighe, Lorenzo Cattarino, Gina Cuomo-Dannenburg, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos Pathogens|March 15, 2014
Clonality of HTLV-2 in natural infectionAnat Melamed, Aviva D Witkover, Daniel J Laydon, et al.
Plos Pathogens|April 18, 2013
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivoNicolas A Gillet, Lucy Cook, Daniel J Laydon, et al.
Retrovirology|January 10, 2016
Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipientsLucy B M Cook, Anat Melamed, Maria Antonietta Demontis, et al.
Scientific Reports|August 12, 2021
Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modellingSwapnil Mishra, James A Scott, Daniel J Laydon, et al.
Nature Communications|September 26, 2025
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemicCharles Whittaker, Gregory Barnsley, Daniela Olivera Mesa, et al.
Vaccine|May 2, 2021
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysisAlexandra B Hogan, Peter Winskill, Oliver J Watson, et al.
Plos Medicine|November 30, 2016
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison StudyStefan Flasche, Mark Jit, Isabel Rodríguez-Barraquer, et al.
Nature|March 26, 2021
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in EnglandErik Volz, Swapnil Mishra, Meera Chand, et al.
Science Translational Medicine|June 23, 2021
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in EnglandEdward S Knock, Lilith K Whittles, John A Lees, et al.
BMC Medicine|October 9, 2020
Response to COVID-19 in South Korea and implications for lifting stringent interventionsAmy Dighe, Lorenzo Cattarino, Gina Cuomo-Dannenburg, et al.
Pageof 4